Why Indian Pharma Needs to Elevate ESG?

At Real Enviro Solutions Pvt. Ltd., we help pharma businesses bridge this gap with ESG reporting, GHG accounting, and decarbonization strategies tailored to international standards.

The Market Reality

• Global buyers & regulators are making ESG compliance mandatory.

• Pharma has a high carbon, water & waste footprint.

• Investors are shifting towards sustainability-linked portfolios.

• ESG is no longer a “good to have” — it’s a growth imperative.

The Gap in India

• Many Indian pharma companies are still in the early stages of ESG adoption.

• Lack of standardized reporting & disclosures.

• Gaps in GHG accounting, carbon footprint tracking, and supply chain transparency.

How We Help

At Real Enviro Solutions, we enable pharma companies to:

• Conduct GHG accounting & carbon footprint assessments.

• Build ESG reporting systems aligned with global standards.

• Design decarbonization & waste reduction strategies.

• Ensure compliance readiness for global audits & regulations.